Pharmacological Characterization of SDX-7320/Evexomostat: a Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-Tumor and Anti-Metastatic Activity
P. Cornelius, B. A. Mayes, J. S. Petersen, D. J. Turnquist, P. J. Dufour, J. M. Shanahan, B. J. Carver
This paper characterizes SDX-7320, a MetAP2 inhibitor, showing reduced CNS toxicity and improved pharmacokinetics compared to previous fumagillin derivatives.
bioRxiv · Feb 29, 2024Pharmacology & Toxicology